Veradermics
Latest round
- Series C
Last raised
- Oct 2025
Total raised
- $224M
Investors
- 16
About Veradermics
Based in Connecticut, US, and founded in 2019, Veradermics, Inc. is a medical dermatology company developing therapeutics. In February 2026, Veradermics, Inc.78 million shares at USD 17 per share, above the USD 14-16 range, on the New York Stock Exchange (NYSE) under the ticker symbol "MANE," valuing the company at approximately USD 596 million. Veradermics focuses on developing skincare treatments, using the expertise of its board-certified dermatologists. The FIRM main product, VDPHL, is a non-hormonal oral treatment taken once a day to treat androgenetic alopecia, or pattern hair loss. The company is also working on four other treatments for common skin conditions, including warts, alopecia areata, molluscum contagiosum, and eczema, for both adults and children. Veradermics primarily sells its products in North America and Europe, aiming to provide solutions for common skin problems.
Who invested in Veradermics
16 investors across 3 rounds
See all investors in Veradermics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Veradermics
Who invested in Veradermics?
Veradermics has 16 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Veradermics raised?
Veradermics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Veradermics last raise money?
Veradermics's most recent round on record is a Series C, in Oct 2025.
What does Veradermics do?
Based in Connecticut, US, and founded in 2019, Veradermics, Inc.
Where is Veradermics headquartered?
Veradermics is headquartered in New Haven, US.
Which VCs invest in companies like Veradermics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Veradermics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Veradermics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.